Donnerstag, 19. Oktober 2017, 13:00 - 19:00 iCal
Editing Genomes with CRISPR: Between Scientific Breakthroughs and Societal Challenges
Billrothhaus, Gesellschaft der Ärzte in Wien
Frankgasse 8, 1090 Wien
Seminar, Workshop, Kurs
Freitag, 20. Oktober 2017, 09:00 - 16:00
An extremely important scientific revolution is taking place with the discovery and development of a gene-editing technology termed CRISPR-Cas9. With this tool, the genomes of various organisms can now be edited with unprecedented specificity and simplicity of use. This opens many possibilities for basic research. It also enables the development of numerous applications in biomedicine, agriculture, in addition to offering novel ways of tackling environmental challenges. The potential implications for the further evolution of species, including our own, as well as for our relationship to nature are profound. Thus, the ongoing scientific revolution opens up questions of safety and ethical responsibility, invokes issues of ownership and social justice, and raises the question of how we can collectively steer research practices towards desirable futures. We believe that decisions on when, where and for what purpose this technology will be applied are also political, not least in terms of their consequences. Thus, directing this discovery towards responsible applications and desirable futures, cannot be left to the sole responsibility of scientists, experts and the industry.
This international symposium aims to discuss the potential impact and challenges while exploring the scientific, ethical, and societal issues inherent in genome-editing research. Inputs by key-note speakers, the presentation of three scenarios where the application of CRISPR is envisioned, interdisciplinary panels, as well as formats encouraging the interaction of the audience with speakers will promote engagement through dialogue.
Um Anmeldung wird gebeten
Insitut für Wissenschafts- und Technikforschung
Erstellt am Dienstag, 12. September 2017, 17:15
Letzte Änderung am Montag, 18. September 2017, 13:07